Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database
Naoto Okada, Takahiro Niimura, Yoshito Zamami, et al.
Cancer Medicine (2018) Vol. 8, Iss. 1, pp. 174-181
Open Access | Times Cited: 21

Showing 21 citing articles:

Risk Signal Mining and Analysis of PCSK9 Inhibitors Based on FAERS Database
Li Peng, Min Xie, Bimin Feng, et al.
(2025)
Closed Access
A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases
Qian Liu, Zhiwei Cui, Chao Deng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Disproportionality Analysis on Hypothyroidism With Roxadustat Using the Japanese Adverse Drug Event Database
Yasunobu Kouki, Naoto Okada, Kosuke Saga, et al.
The Journal of Clinical Pharmacology (2023) Vol. 63, Iss. 10, pp. 1141-1146
Closed Access | Times Cited: 9
Risk Evaluation for Acute Kidney Injury Induced by the Concomitant Use of Valacyclovir, Analgesics, and Renin–Angiotensin System Inhibitors: The Detection of Signals of Drug–Drug Interactions
Ichiro Inaba, Yuki Kondo, Shinya Iwasaki, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 20
Investigation of drugs affecting hypertension in bevacizumab‐treated patients and examination of the impact on the therapeutic effect
Kenta Yagi, Marin Mitstui, Yoshito Zamami, et al.
Cancer Medicine (2020) Vol. 10, Iss. 1, pp. 164-172
Open Access | Times Cited: 17
Investigation of drugs for the prevention of doxorubicin-induced cardiac events using big data analysis
Shiori Nishiuchi, Kenta Yagi, Hiroumi Saito, et al.
European Journal of Pharmacology (2022) Vol. 928, pp. 175083-175083
Open Access | Times Cited: 11
Delirium risk of histamine-2 receptor antagonists and proton pump inhibitors: A study based on the adverse drug event reporting database in Japan
Nao Kikkawa, Rintaro Sogawa, Akira Monji, et al.
General Hospital Psychiatry (2021) Vol. 72, pp. 88-91
Open Access | Times Cited: 12
Risk of delirium with antiepileptic drug use: a study based on the Japanese Adverse Drug Event Report database
Toshiki Kubo, Rintaro Sogawa, Satoko Tsuruhashi, et al.
International Journal of Clinical Pharmacy (2023) Vol. 45, Iss. 5, pp. 1260-1266
Open Access | Times Cited: 4
An Integrated In Silico and In Vivo Approach to Identify Protective Effects of Palonosetron in Cisplatin-Induced Nephrotoxicity
Eri Wakai, Yuya Suzumura, Kenji Ikemura, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 480-480
Open Access | Times Cited: 9
Antihypertensive Drug Combinations Modify Cisplatin-induced Acute Kidney Injury
Koji Takeuchi, Rintaro Sogawa, Satoko Tsuruhashi, et al.
In Vivo (2022) Vol. 36, Iss. 3, pp. 1391-1396
Open Access | Times Cited: 5
Pediatric drug safety signal detection of non-chemotherapy drug-induced neutropenia and agranulocytosis using electronic healthcare records
Ran Wei, Lulu Jia, Yun-Cui Yu, et al.
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 5, pp. 435-441
Closed Access | Times Cited: 7
Comparison of Hemorrhagic Risk between Prasugrel and Clopidogrel: a Retrospective Study using Adverse Drug Event Reporting Databases
Hiromi Hagiwara, Hidekatsu Fukuta, Takahiro Niimura, et al.
International Journal of Medical Sciences (2020) Vol. 17, Iss. 6, pp. 728-733
Open Access | Times Cited: 6
Discovery of preventive drugs for cisplatin‐induced acute kidney injury using big data analysis
Masaya Kanda, Mitsuhiro Goda, Akiko Maegawa, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 7, pp. 1664-1675
Open Access | Times Cited: 4
Effects of imatinib on glycemic and lipid profiles: a retrospective cohort study
Noa Markovits, Daniel Kurnik, Carmel Friedrich, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 9, pp. 2224-2232
Closed Access | Times Cited: 3
Association between age and onset of daptomycin-induced adverse events using the U.S. food and drug administration adverse event reporting system
Chihiro Shiraishi, Hideo Kato, Toru Ogura, et al.
Journal of Infection and Chemotherapy (2024) Vol. 31, Iss. 1, pp. 102501-102501
Open Access
Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System
Naoto Okada, Takahiro Niimura, Atsuyuki Saisyo, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 1
Effect of D-mannose on Philadelphia chromosome-positive leukemia cells
Seiichi Okabe, Yuko Tanaka, Akihiko Gotoh
Cancer Biomarkers (2022) Vol. 34, Iss. 3, pp. 337-346
Closed Access | Times Cited: 2
Delirium Risk of Antiepileptic Drugs: A Study Based on the Adverse Drug Event Reporting Database in Japan
Toshiki Kubo, Rintaro Sogawa, Satoko Tsuruhashi, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Analysis of clinical factors in olaparib-related anemia using adverse drug event reporting databases
Chihiro Shiraishi, Toshinori Hirai, Toru Ogura, et al.
Research Square (Research Square) (2022)
Open Access
2. Establishing Preventive Strategies Against the Side Effects of Anticancer Drugs Using the Medical Large Databases of Spontaneous Adverse Event Reports
Keisuke Ishizawa
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics (2021) Vol. 52, Iss. 2, pp. 47-49
Closed Access
Page 1

Scroll to top